Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

Felix C. Ringshausen, Adam J. Shapiro, Kim G. Nielsen, Henryk Mazurek, Massimo Pifferi, Massimo Pifferi, Menno M. van der Eerden, Michael R. Loebinger, Maimoona A. Zariwala, Margaret W. Leigh, Michael R. Knowles, Thomas W. Ferkol, Felix C. Ringshausen, Adam J. Shapiro, Kim G. Nielsen, Henryk Mazurek, Massimo Pifferi, Henryk Mazurek, Menno M. van der Eerden, Michael R. Loebinger, Maimoona A. Zariwala, Margaret W. Leigh, Michael R. Knowles, Thomas W. Ferkol, Trey Brown, Mary Carroll, Nina L. Church, Marisa Couluris, Stephanie D. Davis, Sharon Dell, Maria Di Cicco, Angela Di Mango, Hugo Murua Escobar, Anne Griffiths, Kenan Haver, Douglas B. Hornick, Christopher Johnson, Carlos Milla, Anne O’Donnell, Isabell Pink, Andrzej Pogorzelski, Michelle Prickett, Benjamin A. Raby, Margaret Rosenfeld, Thomas G. Saba, Rikke Mulvad Sandvik, Scott D. Sagel, Matthias Salathé, Ashley E Simmons, George M. Solomon, Olaf Sommerburg, Najwa Soussi, Steven Strausbaugh, Kelli M. Sullivan, Claudius Werner, Kelli M. Sullivan, Claudius Werner